Sector revisions Granules India Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 11:00:52 17/07/2026 BST			5-day change	1st Jan Change
880.10 ^INR	-2.55%		-1.06%	+47.04%

07-06	Granules India Gets Sole First-to-File Status for Sodium Oxybate Extended-Release for Oral Suspension	MT
07-06	Granules India Limited Secures Sole First-To-File ANDA Status For Sodium Oxybate Extended-Release For Oral Suspension	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	GRANULES INDIA LIMITED							7
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	ROCHE HOLDING AG							18
	NOVARTIS AG							21
	ASTRAZENECA PLC							22
	NOVO NORDISK A/S							24
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							24
	VERTEX PHARMACEUTICALS INCORPORATED							23
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							15
	BAYER AG							18
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	HALEON PLC							17
	Average							21
	Weighted average by Cap.							24